amplification set cmv ibridoquant (Meridian Bioscience)
90
Structured Review
Meridian Bioscience
amplification set cmv ibridoquant
Amplification Set Cmv Ibridoquant, supplied by Meridian Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplification+set+cmv+ibridoquant/amplification+set+cmv+ibridoquant/pm10942490-50-30-34
Average 90 stars, based on 1 article reviews
Amplification Set Cmv Ibridoquant, supplied by Meridian Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amplification+set+cmv+ibridoquant/amplification+set+cmv+ibridoquant/pm10942490-50-30-34
Average 90 stars, based on 1 article reviews
amplification set cmv ibridoquant - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Real-time Polymerase Chain Reaction:Article Title: Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Article Snippet: Cytomegalovirus (CMV) is the most common cause of intrauterine infection, occurring in 0.3% to 2% of all live births.1 Although only 10% to 15% of infected fetuses show symptoms at birth, the clinical manifestations (mainly central nervous system and multiple organ involvement) may be so severe as to lead to a 20% to 30% perinatal mortality rate and major neurologic sequelae in >90% of the surviving babies.. In addition, 5% to 15% of symptom-free neonates have long-term sequelae, mainly mental retardation and deafness.2 All these factors make CMV a major health problem.. Although CMV can be transmitted to the fetus in cases of both primary and secondary maternal infection, it is well known that the former type of infection carries a much greater clinical impact than does recurrent or exogenous reinfection. Amplification:Article Title: Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Article Snippet: Cytomegalovirus (CMV) is the most common cause of intrauterine infection, occurring in 0.3% to 2% of all live births.1 Although only 10% to 15% of infected fetuses show symptoms at birth, the clinical manifestations (mainly central nervous system and multiple organ involvement) may be so severe as to lead to a 20% to 30% perinatal mortality rate and major neurologic sequelae in >90% of the surviving babies.. In addition, 5% to 15% of symptom-free neonates have long-term sequelae, mainly mental retardation and deafness.2 All these factors make CMV a major health problem.. Although CMV can be transmitted to the fetus in cases of both primary and secondary maternal infection, it is well known that the former type of infection carries a much greater clinical impact than does recurrent or exogenous reinfection. |